News Daily News Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients Caitlin E. Cox December 09, 2022
News Industry News Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial December 06, 2022
News Daily News Impella RP Mortality Rate No Longer a Concern, FDA Says Caitlin E. Cox December 05, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2022 Shelley Wood October 31, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Daily News COAPT Risk Score Useful in Predicting Outcomes in Functional MR Michael O'Riordan October 05, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2022 Shelley Wood October 03, 2022
Presentation TCT 2022 TCT 352: Interventional Heart Failure: Current State of the Field Presenter: Miguel Alvarez Villela September 18, 2022
News Conference News TCT 2022 Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD Shelley Wood September 18, 2022
Presentation TCT 2022 What Interventionalist/Structuralists Should Know About the US Guidelines for Medical Therapies for Heart Failure Presenter: Sean Pinney September 17, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
Presentation TCT 2022 The Interventional HF Innovation Landscape: What Is Working and What Is Not! Presenter: Navin Kapur September 16, 2022
Presentation TCT 2022 Moving Beyond Pharmacotherapy: The Transformative Role of Devices in HF Treatment Presenter: William Abraham September 16, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Daily News FDA: Class I Recall of Cobalt and Crome ICDs and CRT-Ds Due to Reduced-Energy Shock L.A. McKeown August 19, 2022